Реваскуляризация миокарда при стабильных формах ишемической болезни сердца: современное состояние проблемы

В обзоре рассмотрены дискуссионные вопросы реваскуляризации миокарда при хронических формах ишемической болезни сердца, показаны принципиальные различия чрескожного коронарного вмешательства и коронарного шунтирования в свете долгосрочного прогноза и зависимость результатов от особенностей клинического профиля заболевания. Анализ современных публикаций свидетельствует о преимуществах открытых операций относительно отдаленной выживаемости и профилактики неблагоприятных исходов в целевых группах больных.

1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, FunckBrentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407–77. DOI: 10.1093/eurheartj/ehz425

2. Yusuf S, Zucker D, Passamani E, Peduzzi P, Takaro T, Fisher LD et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. The Lancet. 1994;344(8922):563–70. DOI: 10.1016/S0140-6736(94)91963-1

3. Grüntzig A. Transluminal dilatation of coronary-artery stenosis. The Lancet. 1978;1(8058):263. DOI: 10.1016/S0140-6736(78)90500-7

4. Ohri SK, Benedetto U, Luthra S, Grant SW, Goodwin AT, Trivedi U et al. Coronary artery bypass surgery in the UK, trends in activity and outcomes from a 15-year complete national series. European Journal of Cardio-Thoracic Surgery. 2022;61(2):449–56. DOI: 10.1093/ejcts/ezab391

5. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394

6. Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021;42(14):1289–367. DOI: 10.1093/eurheartj/ehaa575

7. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year Follow-up: Outcomes of Patients Randomized to Initial Strategies of Medical Therapy Versus Revascularization. Circulation. 1997;95(8):2037–43. DOI: 10.1161/01.CIR.95.8.2037

8. Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R, Hueb W et al. Percutaneous Coronary Intervention Out-comes in Patients With Stable Obstructive Coronary Artery Disease and Myocardial Ischemia: A Collaborative Meta-analysis of Contemporary Randomized Clinical Trials. JAMA Internal Medicine. 2014;174(2):232–40. DOI: 10.1001/jamainternmed.2013.12855

9. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel Disease: Meta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era. JAMA Internal Medicine. 2014;174(2):223–30. DOI: 10.1001/jamainternmed.2013.12844

10. Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC et al. Effect of Diabetes and Associated Conditions on Long-Term Survival After Coronary Artery Bypass Graft Surgery. Circulation. 2004;110(11 Suppl 1):II41-4. DOI: 10.1161/01.CIR.0000138197.07051.e7

11. Doenst T, Sigusch H. Surgical collateralization: The hidden mechanism for improving prognosis in chronic coronary syndromes. The Journal of Thoracic and Cardiovascular Surgery. 2022;163(2):703-708.e2. DOI: 10.1016/j.jtcvs.2020.10.121

12. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. Journal of the American College of Cardiology. 1988;12(1):56–62. DOI: 10.1016/0735-1097(88)90356-7

13. Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B et al. Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years. New England Journal of Medicine. 2019;380(5):437–46. DOI: 10.1056/NEJMoa1808783

14. Gaudino M, Benedetto U, Fremes S, Biondi-Zoccai G, Sedrakyan A, Puskas JD et al. Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery. New England Journal of Medicine. 2018;378(22):2069–77. DOI: 10.1056/NEJMoa1716026

15. Doenst T, Haverich A, Serruys P, Bonow RO, Kappetein P, Falk V et al. PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. Journal of the American College of Cardiology. 2019;73(8):964–76. DOI: 10.1016/j.jacc.2018.11.053

16. Park S-J, Ahn J-M, Kim Y-H, Park D-W, Yun S-C, Lee J-Y et al. Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. New England Journal of Medicine. 2015;372(13):1204–12. DOI: 10.1056/NEJMoa1415447

17. Park SJ, Ahn JM. Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. New England Journal of Medicine. 2015;373(6):581– 2. DOI: 10.1056/NEJMc1506944

18. Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. New England Journal of Medicine. 2016;375(23):2223–35. DOI: 10.1056/NEJMoa1610227

19. Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IBA et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. The Lancet. 2016;388(10061):2743–52. DOI: 10.1016/S0140-6736(16)32052-9

20. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M et al. Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine. 2012;367(25):2375–84. DOI: 10.1056/NEJMoa1211585

21. Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS et al. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM follow-on study. Journal of the American College of Cardiology. 2019;73(6):629–38. DOI: 10.1016/j.jacc.2018.11.001

22. Bianco V, Kilic A, Mulukutla SR, Gleason TG, Kliner D, Aranda-Michel E et al. Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention in Patients With Diabetes. Seminars in Thora cic and Cardiovascular Surgery. 2021;33(2):368–77. DOI: 10.1053/j.semtcvs.2020.07.003

23. Head SJ, Milojevic M, Daemen J, Ahn J-M, Boersma E, Christiansen EH et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. The Lancet. 2018;391(10124):939–48. DOI: 10.1016/S0140-6736(18)30423-9

24. Gallo M, Blitzer D, Laforgia PL, Doulamis IP, Perrin N, Bortolussi G et al. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. 2022;163(1):94-105.e15. DOI: 10.1016/j.jtcvs.2020.04.010

25. De Filippo O, Di Franco A, Boretto P, Bruno F, Cusenza V, Desalvo P et al. Percutaneous coronary intervention versus coronary artery surgery for left main disease according to lesion site: A meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. 2021;S00225223(21)01238-1. [Epub ahead of print]. DOI: 10.1016/j.jtcvs.2021.08.040

26. Gaudino M, Di Franco A, Spadaccio C, Rahouma M, Robinson NB, Demetres M et al. Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. 2023;165(2):662-669.e14. DOI: 10.1016/j.jtcvs.2021.04.062

27. Sun LY, Gaudino M, Chen RJ, Bader Eddeen A, Ruel M. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting. JAMA Cardiology. 2020;5(6):631–41. DOI: 10.1001/jamacardio.2020.0239

28. Ruel M, Farkouh ME. Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials. Circulation. 2017;135(9):822–4. DOI: 10.1161/CIRCULATIONAHA.116.027159

29. Lamelas P, Belardi J, Whitlock R, Stone GW. Limitations of Repeat Revascularization as an Outcome Measure. Journal of the American College of Cardiology. 2019;74(25):3164–73. DOI: 10.1016/j.jacc.2019.10.041

30. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2019;40(3):237–69. DOI: 10.1093/eurheartj/ehy462

31. Genereux P, Serruys P, Kappetein A, Boven AV, Hickey M, Kandzari D et al. Differences and level of agreement in SYNTAX Score assessment between site operators and angiographic core laboratory readers: insights from the EXCEL trial. Journal of the American College of Cardiology. 2017;69(11):1147. DOI: 10.1016/S0735-1097(17)34536-9

32. Pinho-Gomes A-C, Azevedo L, Ahn J-M, Park S-J, Hamza TH, Farkouh ME et al. Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials. Journal of the American College of Cardiology. 2018;71(6):591–602. DOI: 10.1016/j.jacc.2017.11.068

33. Lee PH, Ahn J-M, Chang M, Baek S, Yoon S-H, Kang S-J et al. Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes. Journal of the American College of Cardiology. 2016;68(11):1233–46. DOI: 10.1016/j.jacc.2016.05.089

34. Ngu JMC, Sun LY, Ruel M. Pivotal contemporary trials of percutaneous coronary intervention vs. coronary artery bypass grafting: a surgical perspective. Annals of Cardiothoracic Surgery. 2018;7(4):527–32. DOI: 10.21037/acs.2018.05.12

35. Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine. 2009;360(10):961–72. DOI: 10.1056/NEJMoa0804626

36. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M et al. Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization. Journal of the American College of Cardiology. 2008;51(5):538–45. DOI: 10.1016/j.jacc.2007.09.054

37. Ahn J-M, Roh J-H, Kim Y-H, Park D-W, Yun S-C, Lee PH et al. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease. Journal of the American College of Cardiology. 2015;65(20):2198–206. DOI: 10.1016/j.jacc.2015.03.033

38. Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T et al. Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis. Journal of the American College of Cardiology. 2011;57(5):538–45. DOI: 10.1016/j.jacc.2010.09.038

39. Capodanno D, Stone GW, Morice MC, Bass TA, Tamburino C. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease. Journal of the American College of Cardiology. 2011;58(14):1426–32. DOI: 10.1016/j.jacc.2011.07.005

40. Esper RB, Farkouh ME, Ribeiro EE, Hueb W, Domanski M, Hamza TH et al. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial. Journal of the American College of Cardiology. 2018;72(23 Pt A):2826–37. DOI: 10.1016/j.jacc.2018.09.046

41. Kassimis G, Bourantas CV, Tushar R, de Maria GL, Davlouros P, Hahalis G et al. Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going? Hellenic Journal of Cardiology. 2017;58(3):178–89. DOI: 10.1016/j.hjc.2017.01.028

42. Kalra K, Chen EP. Commentary: Finding the Sweeter Fruit: Optimal Treatment of Diabetics With CAD. Seminars in Thoracic and Cardiovascular Surgery. 2021;33(2):380–1. DOI: 10.1053/j.semtcvs.2020.09.017

43. BARI Investigators. The Final 10-Year Follow-Up Results From the BARI Randomized Trial. Journal of the American College of Cardiology. 2007;49(15):1600–6. DOI: 10.1016/j.jacc.2006.11.048

44. Asai T. Commentary: Spontaneous myocardial infarctions and the vital choice: Bypass or stent. The Journal of Thoracic and Cardiovascular Surgery. 2023;165(2):670–1. DOI: 10.1016/j.jtcvs.2021.05.005

45. Lytle B, Gaudino M. Fractional Flow Reserve for Coronary Artery Bypass Surgery. Circulation. 2020;142(14):1315–6. DOI: 10.1161/CIRCULATIONAHA.120.050818

46. Elgendy IY, Mahtta D, Pepine CJ. Medical Therapy for Heart Failure Caused by Ischemic Heart Disease. Circulation Research. 2019;124(11):1520–35. DOI: 10.1161/CIRCRESAHA.118.313568

47. Bakaeen FG, Gaudino M, Whitman G, Doenst T, Ruel M, Taggart DP et al. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. The Journal of Thoracic and Cardiovascular Surgery. 2021;162(3):829-850.e1. DOI: 10.1016/j.jtcvs.2021.04.052

48. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A et al. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. New England Journal of Medicine. 2011;364(17):1607–16. DOI: 10.1056/NEJMoa1100356

49. Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA et al. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. New England Journal of Medicine. 2016;374(16):1511–20. DOI: 10.1056/NEJMoa1602001

50. Wolff G, Dimitroulis D, Andreotti F, Kołodziejczak M, Jung C, Scicchitano P et al. Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis. Circulation: Heart Failure. 2017;10(1):e003255. DOI: 10.1161/CIRCHEARTFAIL-URE.116.003255

51. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Hannan EL. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. Circulation. 2016;133(22):2132–40. DOI: 10.1161/CIRCULATIONAHA.115.021168

52. Völz S, Redfors B, Angerås O, Ioanes D, Odenstedt J, Koul S et al. Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). European Heart Journal. 2021;42(27):2657–64. DOI: 10.1093/eurheartj/ehab273

53. Gaudino M, Castelvecchio S, Rahouma M, Robinson NB, Audisio K, Soletti GJ et al. Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial. The Journal of Thoracic and Cardiovascular Surgery. 2022;S0022-5223(22)00493-7. [Epub ahead of print]. DOI: 10.1016/j.jtcvs.2022.04.016

54. Habib RH, Dimitrova KR, Badour SA, Yammine MB, El-Hage-Sleiman A-KM, Hoffman DM et al. CABG Versus PCI: greater benefit in long-term outcomes with multiple arterial bypass grafting. Journal of the American College of Cardiology. 2015;66(13):1417–27. DOI: 10.1016/j.jacc.2015.07.060

55. Raja SG, Benedetto U, Ilsley CD, Amrani M. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis. International Journal of Cardiology. 2015;189:153–8. DOI: 10.1016/j.ijcard.2015.04.059

56. Rocha RV, Fang J, Tam DY, Elbatarny M, Austin PC, Gaudino MFL et al. Multiple arterial coronary bypass grafting is associated with better survival compared with second-generation drug-eluting stents in patients with stable multivessel coronary artery disease. The Journal of Thoracic and Cardiovascular Surgery. 2021;S0022-5223(21)018134. [Epub ahead of print]. DOI: 10.1016/j.jtcvs.2021.12.026

57. Gaudino M, Taggart DP. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting: A Surgical Perspective. JAMA Cardiology. 2019;4(6):505–6. DOI: 10.1001/jamacardio.2019.1046

58. Bianco V, Kilic A, Aranda-Michel E, Serna-Gallegos D, Ferdinand F, Dunn-Lewis C et al. Complete revascularization during coronary artery bypass grafting is associated with reduced major adverse events. The Journal of Thoracic and Cardiovascular Surgery. 2021;S00225223(21)00900-4. [Epub ahead of print]. DOI: 10.1016/j.jtcvs.2021.05.046

59. Sabik JF, Bakaeen FG, Ruel M, Moon MR, Malaisrie SC, Calhoon JH et al. The American Association for Thoracic Surgery and The Society of Thoracic Surgeons reasoning for not endorsing the 2021 ACC/ AHA/SCAI Coronary Revascularization Guidelines. The Journal of Thoracic and Cardiovascular Surgery. 2022;163(4):1362–5. DOI: 10.1016/j.jtcvs.2021.12.025

60. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. New England Journal of Medicine. 2020;382(15):1395–407. DOI: 10.1056/NEJMoa1915922

61. Hannan EL, Racz MJ, Gold J, Cozzens K, Stamato NJ, Powell T et al. Adherence of Catheterization Laboratory Cardiologists to American College of Cardiology/American Heart Association Guidelines for Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery: What Happens in Actual Practice? Circulation. 2010;121(2):267–75. DOI: 10.1161/CIRCULATIONAHA.109.887539